Drugs in MeSH Category Phosphodiesterase 5 Inhibitors
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hibrow Hlthcare | TADALAFIL | tadalafil | TABLET;ORAL | 217606-003 | Aug 13, 2024 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hetero Labs Ltd Iii | TADALAFIL | tadalafil | TABLET;ORAL | 209908-004 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Ajanta Pharma Ltd | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 206401-001 | Oct 12, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Watson Labs Inc | TADALAFIL | tadalafil | TABLET;ORAL | 205885-001 | Mar 29, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Unichem | TADALAFIL | tadalafil | TABLET;ORAL | 209250-003 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Unichem | TADALAFIL | tadalafil | TABLET;ORAL | 209250-001 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
